Basics Arvinas, Inc. IPO Date: September 24, 2018 Sector: Healthcare Industry: Biotech Market Cap: $574.86M Activated in VL: True Average Daily Range Avg Daily Range: $1.07 | 2.95% Avg Daily Range (30 D): $0.16 | 2.22% Avg Daily Range (90 D): $0.20 | 2.70% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): 1.53M Avg Daily Volume (90 D): 1.9M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 99 Avg Trade Size (Sh.) (90 D): 102 Institutional Trades Total Inst.Trades: 3,048 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $1.5M Avg Inst. Trade (90 D): $1.62M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.62M Avg Closing Trade (30 D): $1.6M Avg Closing Trade (90 D): $1.77M Avg Closing Volume: 83.25K     News Aug 29, 2025 @ 11:00 AM Arvinas to Participate in Upcoming Investor Confer... Source: Arvinas, Inc. Jun 13, 2025 @ 11:00 AM Arvinas Presents Preclinical Data for PROTAC BCL6 ... Source: N/A Jun 6, 2025 @ 11:00 AM Arvinas Announces Submission of New Drug Applicati... Source: N/A May 6, 2025 @ 10:00 PM Kirby McInerney LLP Announces Investigation of Cla... Source: N/A Apr 30, 2025 @ 5:00 PM Metastatic HR+/HER2- Breast Cancer Market—T... Source: Delveinsight Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.84 $1.14 Diluted EPS $-.84 $1.14 Revenue $ $ 22.4M $ 188.8M Gross Profit $ $ $ Net Income / Loss $ $ -61.2M $ 82.9M Operating Income / Loss $ $ -71.5M $ 71.4M Cost of Revenue $ $ $ Net Cash Flow $ $ 33.9M $ -19.5M PE Ratio